BGI EUROPE A/S: Financial statements 2012
CVR: 32931340
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BGI EUROPE A/S (CVR 32931340) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 11,269,751 and a net result of DKK 800,292. Equity in the 2012 report amounted to DKK 6,295,896. The solvency ratio was 19.9%.
- Gross Profit
- DKK 11,269,751
- Profit/Loss
- DKK 800,292
- Equity
- DKK 6,295,896
- Total Assets
- DKK 31,640,655
Official annual report
Keep an eye on BGI EUROPE A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 7, 2012, Jian Wang has joined the board of directors of BGI EUROPE A/S.
As of May 7, 2012, Shengquan Huang has joined the board of directors of BGI EUROPE A/S.
As of May 7, 2012, Yingrui Li has joined the board of directors of BGI EUROPE A/S.
As of May 7, 2012, Songgang Li has left the board of directors of BGI EUROPE A/S.
As of May 7, 2012, Tong Zhang has left the board of directors of BGI EUROPE A/S.
As of May 7, 2012, Man Fung Mak has left the board of directors of BGI EUROPE A/S.
About BGI EUROPE A/S
BGI EUROPE A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of JUN CHENG. The board consists of Ning Li (chair), CAO Sujie, Hao Zeng and JUN CHENG. The company is owned by BGI Genomics Co., Ltd.. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -5,028,063 and a net result of DKK -32,211,033 compared with DKK -15,695,243 the year before. Equity in the 2025 report amounted to DKK -1,950,676.